Overview

Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects

Status:
Completed

Trial end date:
2019-04-01

Target enrollment:

Participant gender:

Summary

This is a single-center, open-label study to assess safety and pharmacokinetics of VNRX-5133 and cefepime in the epithelial lining fluid in healthy adult male and female subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Venatorx Pharmaceuticals, Inc.

Collaborator:

National Institutes of Health (NIH)

Treatments:

Cefepime